1) Paragraph IV litigations
Cephalon, Inc. Vs Apotex, Inc (Product: may be Armodafinil )
Complaint filed at Delaware District Court on December 14, 2010
2) Meda acquires three OTC products from Glaxo in the US (Business wire); Product information is not disclosed. Glaxo markets totally five OTC product (TAGAMET HB; ABREVA; NICORETTE; COMMIT; ALLI) in US.
3) Reckitt Benckiser to buy India’s Paras for $726 mn (ET)
4) Inspire Announces Launch of DIQUASTM Ophthalmic Solution 3% (diquafosol tetrasodium) by Santen in Japan (Yahoo finance)
5) New dosing recommandation for Darunavir is approved by FDA (J&J Press release); Ritonavir is HIV protease inhibitor and also CYP3A4 (a metabolic enzyme); This reduces metabolic clearance of other agent administered with ritonavir . We aware of approved combination of Lopinavir and Ritonavir.